Physician Assistant Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Hannah Ammon

Procedural Dermatology Columbus, OH Physician Assistant

NPI 1922719798 CMS profile 11498885

3380 Tremont Rd Ste 140, Columbus, OH 43221

Open in the dashboard

General payments

$6,008

323 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hannah Ammon of Columbus, OH is reported in the CMS Open Payments database as having received $6,008 across 323 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Procedural Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,353 188
2024 General $2,437 128
2023 General $218 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hannah Ammon
  • Procedural Dermatology median
  • Middle half of Procedural Dermatology
  • National median

In program year 2025, general payments to Hannah Ammon were reported at $3,353. Among 381 Procedural Dermatology profiles paid that year, the median was $592 and the middle half received between $144 and $1,778.

Show as a table
Year Hannah Ammon Procedural Dermatology median Middle half National median
2019 $0 $454 $152–$1,260 $163
2020 $0 $243 $90–$835 $114
2021 $0 $337 $102–$1,128 $132
2022 $0 $443 $119–$1,654 $149
2023 $218 $583 $137–$1,838 $160
2024 $2,437 $611 $132–$1,835 $164
2025 $3,353 $592 $144–$1,778 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Janssen Biotech, Inc. $1,066 31 payments
  2. Pfizer Inc. $569 50 payments
  3. AbbVie, Inc. $546 36 payments
  4. Mayne Pharma Inc. $533 53 payments
  5. UCB, Inc. $463 23 payments
  6. Genzyme Corporation $383 11 payments
  7. Incyte Corporation $339 23 payments
  8. Regeneron Healthcare Solutions, Inc. $294 10 payments
  9. Organon LLC $273 13 payments
  10. E.R. Squibb & Sons, L.L.C. $269 12 payments
  11. Other $1,274 61 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $5,709 319 payments
  2. Education $299 4 payments
Products named General payments · program years 2023–2025
  1. TREMFYA $1,107 32 payments
  2. DUPIXENT $583 14 payments
  3. LITFULO $553 49 payments
  4. Bimzelx $463 23 payments
  5. CIBINQO $438 48 payments
  6. OPZELURA $339 23 payments
  7. SKYRIZI Immunology $309 19 payments
  8. SOTYKTU $269 12 payments
  9. VTAMA $243 7 payments
  10. SKYRIZI Immunology $222 16 payments
  11. Other $1,334 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

74

Median for Physician Assistant: 241

Drug cost

$1,624

Median for Physician Assistant: $4,110

Branded share of claims

0%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clobetasol Propionate Generic 13 $591
Ketoconazole Generic 21 $472
Triamcinolone Acetonide Generic 26 $373
Hydrocortisone Generic 14 $187

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$8,834

Medicare's payments for the services billed

Medicare patients

68

Average age 76

Services billed

189

39 women, 29 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 49%
Osteoporosis 29%
Chronic kidney disease 25%
Ischemic heart disease 24%
Depression 24%
Cancer 18%
Diabetes 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 17 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $681
  • Janssen Scientific Affairs, LLC $42
$722 — —
DUPIXENT
  • SANOFI-AVENTIS U.S. LLC $99
  • Regeneron Healthcare Solutions, Inc. $82
  • GENZYME CORPORATION $36
$217 — —
SKYRIZI
  • AbbVie, Inc. $206
$206 — —
Bimzelx
  • UCB, Inc. $155
$155 — —
YCANTH
  • VERRICA PHARMACEUTICALS INC. $149
$149 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 17 in the dashboard with a free account

Records

323 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Procedural Dermatology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record